Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
Publication
, Journal Article
Desai, MY; Saberi, S; Geske, JB; Wang, A; Cremer, P; Fermin, DR; Zenker, MA; Lakdawala, NK; Tower-Rader, A; Naidu, SS; Lampl, K; Owens, A ...
Published in: JACC Heart Fail
June 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
June 2025
Volume
13
Issue
6
Start / End Page
1037 / 1040
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Desai, M. Y., Saberi, S., Geske, J. B., Wang, A., Cremer, P., Fermin, D. R., … VALOR-HCM Investigators. (2025). Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial. JACC Heart Fail, 13(6), 1037–1040. https://doi.org/10.1016/j.jchf.2025.02.005
Desai, Milind Y., Sara Saberi, Jeffrey B. Geske, Andrew Wang, Paul Cremer, David R. Fermin, Mark A. Zenker, et al. “Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.” JACC Heart Fail 13, no. 6 (June 2025): 1037–40. https://doi.org/10.1016/j.jchf.2025.02.005.
Desai MY, Saberi S, Geske JB, Wang A, Cremer P, Fermin DR, et al. Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial. JACC Heart Fail. 2025 Jun;13(6):1037–40.
Desai, Milind Y., et al. “Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.” JACC Heart Fail, vol. 13, no. 6, June 2025, pp. 1037–40. Pubmed, doi:10.1016/j.jchf.2025.02.005.
Desai MY, Saberi S, Geske JB, Wang A, Cremer P, Fermin DR, Zenker MA, Lakdawala NK, Tower-Rader A, Naidu SS, Lampl K, Owens A, VALOR-HCM Investigators. Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial. JACC Heart Fail. 2025 Jun;13(6):1037–1040.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
June 2025
Volume
13
Issue
6
Start / End Page
1037 / 1040
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology